|
ST7L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4295011275276E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46399999900737E-08 |
| Normal-vs-Stage2 |
2.14789999999354E-05 |
| Normal-vs-Stage3 |
3.98699961934312E-11 |
| Normal-vs-Stage4 |
1.43680001229995E-09 |
| Stage1-vs-Stage2 |
9.035800E-01 |
| Stage1-vs-Stage3 |
2.576300E-02 |
| Stage1-vs-Stage4 |
4.886500E-02 |
| Stage2-vs-Stage3 |
1.552230E-01 |
| Stage2-vs-Stage4 |
2.279400E-01 |
| Stage3-vs-Stage4 |
8.423400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.01836333704841E-12 |
| Normal-vs-AfricanAmerican |
1.052390E-02 |
| Normal-vs-Asian |
9.00810000037389E-07 |
| Caucasian-vs-AfricanAmerican |
6.848300E-02 |
| Caucasian-vs-Asian |
7.900200E-01 |
| AfricanAmerican-vs-Asian |
1.688560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.72729616668244E-11 |
| Normal-vs-Female |
1.17800003085478E-09 |
| Male-vs-Female |
1.920190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.31940000036579E-08 |
| Normal-vs-Age(41-60Yrs) |
6.5160999929148E-09 |
| Normal-vs-Age(61-80Yrs) |
2.28109975353163E-10 |
| Normal-vs-Age(81-100Yrs) |
9.039800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.046600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.005800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.700600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.538000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.702600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.378600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.54113999999428E-05 |
| Classical-VS-Follicular |
7.518400E-01 |
| Classical-VS-Other |
2.977000E-01 |
| Classical-VS-Normal |
2.50300002946346E-09 |
| Tall-VS-Follicular |
5.433900E-04 |
| Tall-VS-Other |
3.563000E-01 |
| Tall-VS-Normal |
1.35225164399344E-12 |
| Follicular-VS-Other |
4.285400E-01 |
| Follicular-VS-Normal |
1.78439999998226E-06 |
| Other-VS-Normal |
2.603600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.69559999163971E-09 |
| Normal-vs-N1 |
9.03439989485832E-10 |
| N0-vs-N1 |
1.141640E-01 |
|
|
